Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study

Respirology

Volumn 16, Issue 7, 2011, Pages 1150-1156

  Faruqi, Shoaib ^a   Molyneux, Ian D ^a   Fathi, Hosnieh ^a   Wright, Caroline ^a   Thompson, Rachael ^a   Morice, Alyn H ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

cough; proton pump inhibitor; reflux

Indexed keywords

CITRIC ACID; ESOMEPRAZOLE; PLACEBO;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL CONDITION IMPROVEMENT; HUMAN; LARYNGOSCOPY; MALE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SMOKING; SPIROMETRY; SYMPTOM; TREATMENT DURATION;

CHRONIC DISEASE; COUGH; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80053319041     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02014.x     Document Type: Article

References (42)

1. DeVault KR, Castell DO,. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 1999; 94: 1434-42. (Pubitemid 29260426)
2. Irwin RS, Baumann MH, Bolser DC, et al,. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 1S-23S. (Pubitemid 43265198)
3. Morice AH, Fontana GA, Sovijarvi AR,. The diagnosis and management of chronic cough. Eur. Respir. J. 2004; 24: 481-92. (Pubitemid 39232274)
4. Pratter MR, Brightling CE, Boulet LP, et al,. An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 222S-31S. (Pubitemid 43265226)
5. Chang AB, Lasserson TJ, Kiljander TO, et al,. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. Br. Med. J. 2006; 332: 11-17.
6. Everett CF, Morice AH,. Clinical history in gastroesophageal cough. Respir. Med. 2007; 101: 345-8. (Pubitemid 46075972)
7. Morice AH, Menon MS, Mulrennan SA, et al,. Opiate therapy in chronic cough. Am. J. Respir. Crit. Care Med. 2007; 175: 312-15.
8. Birring SS, Prudon B, Carr AJ, et al,. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003; 58: 339-43. (Pubitemid 36411421)
9. Morice AH, Faruqi S, Wright CE, et al,. Cough hypersensitivity syndrome: a distinct clinical entity. Lung 2011; 189: 73-9.
10. Belafsky PC, Postma GN, Koufman JA,. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111: 1313-17. (Pubitemid 32730172)
11. Morice AH, Fontana GA, Belvisi MG, et al,. ERS guidelines on the assessment of cough. Eur. Respir. J. 2007; 29: 1256-76. (Pubitemid 46895388)
12. FitzGerald JM, Allen CJ, Craven MA, et al,. Chronic cough and gastroesophageal reflux. CMAJ 1989; 140: 520-4. (Pubitemid 19081278)
13. Irwin RS, Corrao WM, Pratter MR,. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am. Rev. Respir. Dis. 1981; 123: 413-17. (Pubitemid 11105709)
14. Ing AJ, Ngu MC, Breslin AB,. Chronic persistent cough and gastro-oesophageal reflux. Thorax 1991; 46: 479-83.
15. Irwin RS, Zawacki JK, Curley FJ, et al,. Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am. Rev. Respir. Dis. 1989; 140: 1294-300. (Pubitemid 19276212)
16. Waring JP, Lacayo L, Hunter J, et al,. Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease. Diagnosis and response to therapy. Dig. Dis. Sci. 1995; 40: 1093-7.
17. Irwin RS, Zawacki JK, Wilson MM, et al,. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002; 121: 1132-40. (Pubitemid 34280433)
18. Wo JM, Koopman J, Harrell SP, et al,. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am. J. Gastroenterol. 2006; 101: 1972-8. (Pubitemid 44337618)
19. Vaezi MF, Richter JE, Stasney CR, et al,. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-60. (Pubitemid 44383934)
20. Noordzij JP, Khidr A, Evans BA, et al,. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147-51. (Pubitemid 33117214)
21. Eherer AJ, Habermann W, Hammer HF, et al,. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand. J. Gastroenterol. 2003; 38: 462-7. (Pubitemid 36609848)
22. Shaheen NJ, Crockett SD, Bright SD, et al,. Randomised clinical trial: high-dose acid suppression for chronic cough-a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 2011; 33: 225-34.
23. Faruqi S, Thompson R, Wright C, et al,. Quantifying chronic cough: objective versus subjective measurements. Respirology 2011; 16: 314-20.
24. Decalmer SC, Webster D, Kelsall AA, et al,. Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? Thorax 2007; 62: 329-34. (Pubitemid 46580576)
25. Eccles R,. The powerful placebo in cough studies? Pulm. Pharmacol. Ther. 2002; 15: 303-8. (Pubitemid 34754125)
26. Rostami-Hodjegan A, Abdul-Manap R, Wright CE, et al,. The placebo response to citric acid-induced cough: pharmacodynamics and gender differences. Pulm. Pharmacol. Ther. 2001; 14: 315-19. (Pubitemid 32625019)
27. Beecher HK,. The powerful placebo. JAMA 1955; 159: 1602-6.
28. Vertigan AE, Theodoros DG, Gibson PG, et al,. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006; 61: 1065-9. (Pubitemid 44852025)
29. Wager TD, Scott DJ, Zubieta JK,. Placebo effects on human mu-opioid activity during pain. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 11056-61. (Pubitemid 47175225)
30. Mastronarde JG, Anthonisen NR, Castro M, et al,. Efficacy of esomeprazole for treatment of poorly controlled asthma. N. Engl. J. Med. 2009; 360: 1487-99.
31. Lenglinger J, Riegler M,. Esomeprazole for asthma. N. Engl. J. Med. 2009; 361: 206-7.
32. Hemmink GJ, Bredenoord AJ, Weusten BL, et al,. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am. J. Gastroenterol. 2008; 103: 2446-53.
33. Blondeau K, Dupont LJ, Mertens V, et al,. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment. Pharmacol. Ther. 2007; 25: 723-32.
34. Laheij RJ, Van Ijzendoorn MC, Janssen MJ, et al,. Gastric acid-suppressive therapy and community-acquired respiratory infections. Aliment. Pharmacol. Ther. 2003; 18: 847-51. (Pubitemid 37323651)
35. Herzig SJ, Howell MD, Ngo LH, et al,. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301: 2120-8.
36. Gulmez SE, Holm A, Frederiksen H, et al,. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch. Intern. Med. 2007; 167: 950-5. (Pubitemid 46762758)
37. Yearsley KA, Gilby LJ, Ramadas AV, et al,. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment. Pharmacol. Ther. 2006; 24: 613-19. (Pubitemid 44127842)
38. Dial SJ, Delaney JA, Barkun AN, et al,. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-95. (Pubitemid 41817660)
39. Yang YX,. Proton pump inhibitor therapy and osteoporosis. Curr. Drug Saf. 2008; 3: 204-9.
40. Corley DA, Kubo A, Zhao W, et al,. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 2010; 139: 93-101.
41. Gilard M, Arnaud B, Cornily JC, et al,. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J. Am. Coll. Cardiol. 2008; 51: 256-60.
42. Juurlink DN, Gomes T, Ko DT, et al,. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180: 713-18.